Results 41 to 50 of about 138,445 (169)

Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery

open access: yesMedicines, 2017
Mesenchymal stromal cells are a population of undifferentiated multipotent adult cells possessing extensive self-renewal properties and the potential to differentiate into a variety of mesenchymal lineage cells.
Francesco Petrella   +3 more
doaj   +1 more source

Mesenchymal stromal cells: more than inhibitory cells [PDF]

open access: yesLeukemia, 2011
Mesenchymal stem cells, cautiously re-named recently multipotent mesenchymal stromal cells (MSCs) because of their heterogeneous multipotency at single cell level and their similarities with fibroblasts, have been strongly suggested in the last decade as powerful inhibitory cells for the vast majority of immune effector cells.
openaire   +2 more sources

Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model

open access: yesFrontiers in Endocrinology, 2019
Introduction: Cell therapy can overcome the limitation of conventional treatments (including different medications and β cell replacement) for type 1 diabetes.
Babak Arjmand   +8 more
doaj   +1 more source

Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survival

open access: yesHaematologica, 2011
Background Bone marrow mesenchymal stromal cells can suppress T-lymphocyte proliferation but promote survival of normal and malignant B cells, thus representing a possible target for new therapeutic schemes.
Alessandra Musso   +2 more
doaj   +1 more source

Interplay between mesenchymal stromal cells and the immune system after transplantation: implications for advanced cell therapy in the retina

open access: yesNeural Regeneration Research
Advanced mesenchymal stromal cell-based therapies for neurodegenerative diseases are widely investigated in preclinical models. Mesenchymal stromal cells are well positioned as therapeutics because they address the underlying mechanisms of ...
María Norte-Muñoz   +4 more
doaj   +1 more source

Mesenchymal stem cells: the fibroblasts’ new clothes?

open access: yesHaematologica, 2009
Mesenchymal stem cells are adherent stromal cells, initially isolated from the bone marrow, characterized by their ability to differentiate into mesenchymal tissues such as bone, cartilage and fat.
Muzlifah A. Haniffa   +3 more
doaj   +1 more source

Mesenchymal stromal cells – Where art thou? [PDF]

open access: yesJournal of Hepatology, 2015
Mesenchymal stromal cells (MSC) have potent immunomodulatory properties which have led to them being considered as a novel therapeutic modality across a wide range of clinical areas including conditions such as steroid refractory paediatric graft vs. host disease (GVHD) where they are licensed in New Zealand and Canada.
Vasanthy, Vigneswara, Philip N, Newsome
openaire   +2 more sources

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

open access: yesHaematologica, 2012
Background Recent findings suggest that a specific deletion of Dicer1 in mesenchymal stromal cell-derived osteoprogenitors triggers several features of myelodysplastic syndrome in a murine model.
Carlos Santamaría   +13 more
doaj   +1 more source

Mesenchymal Stromal Cells and Viral Infection [PDF]

open access: yesStem Cells International, 2015
Mesenchymal Stromal Cells (MSCs) are a subset of nonhematopoietic adult stem cells, readily isolated from various tissues and easily culture-expandedex vivo. Intensive studies of the immune modulation and tissue regeneration over the past few years have demonstrated the great potential of MSCs for the prevention and treatment of steroid-resistant acute
Maytawan Thanunchai   +2 more
openaire   +3 more sources

A spiked human proteomic dataset from human osteogenic differentiated BMSCs and ASCs for use as a spectral library, for modelling pathways as well as protein mapping

open access: yesData in Brief, 2019
This article describes a mass spectrometry data set generated from osteogenic differentiated bone marrow stromal cells (BMSCs) and adipose tissue derived stromal cells (ASCs) of a 24-year old healthy donor.
Mehran Dadras   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy